Infectious Diseases in Adults 2026
- Continuing Education
Infectious Diseases in Adults 2026 provides state-of-the-art approaches for the prevention, diagnosis, and management of infectious diseases: common, challenging, rare, and emerging.
- Live Online
This program uses state-of-the-art streaming technology to present sessions online in real time. Participants can attend from any location, and can interact with faculty via live chat.
Additionally, all sessions will be recorded and made available to participants for online viewing for 90 days after the end of the course.
All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
$1,375
This is the full course tuition; A $100 early registration discount is available.
For tuition for Residents and Fellows, please see the full table below.
Early Registration Deadline:
Continuing Education
Earn up to:
» 45.25 AMA PRA Category 1 Credits™
» 45.25 ABIM MOC points
» 45.25 ACPE CPE credit hours
» 45.25 ECME Credits®
» 9.25 credits of Risk Management Study, including 6.25 credits of Opioid Education and Pain Management Training
» Commensurate credits through the Royal College of Physicians and Surgeons of Canada
5 Days
This 5-day intensive course, which is among the highest-rated Harvard Medical School CME courses, presents the most up-to-date, evidence-based approaches to infectious diseases.
On This Page
Overview
State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases
Infectious Diseases in Adults 2026 is LIVE STREAMED with on-demand access available for 90 days after the course.
This comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:
- Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases
- Newer antimicrobials and treatment strategies for highly resistant infections
- Prevention and treatment of infections in immunocompromised hosts
- Update on antifungal diagnostics and therapy
- State-of-the-art and multidisciplinary approaches to common infections
- Clinical approaches to complex, rare, and "don't-miss" infections
- New, evolving, emerging, and re-emerging infectious diseases
- Infections in persons with substance use disorder
- What’s new in HIV prevention and management
- The latest on COVID-19, including long COVID
As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 90 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
Highlights of the 2026 Program
Expanded Case-Based and Problem-Solving Education
The 2026 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops. Our speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care. Our ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, native and prosthetic valve endocarditis, musculoskeletal infections, and nontuberculous mycobacterial infections.
Treating Highly Resistant Infections, including:
- MRSA and VISA (vancomycin-intermediate Staph aureus)
- Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods
- Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms
- Vancomycin-resistant enterococci (VRE)
- Aspergillus and non-aspergillus mold infections
- Candida auris
- Nontuberculous mycobacteria (NTM)
Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment
Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:
- Respiratory viral infections, including COVID-19
- New and updated vaccines
- Infections in the expanding populations of immunocompromised hosts
- Infections in persons with substance use disorder
- Infections of travelers and foreign-born persons
- Systemic fungal infections
- Native and device-related orthopedic infections
- Central nervous system (CNS) infections
- Ear, nose, and throat (ENT) and eye infections
- Skin and soft tissue infections
- Bronchiectasis and pneumonia
- HIV and its infectious and noninfectious complications
- PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
- Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs
- Hepatitis B and C infections
- Tick- and mosquito-borne infections
- Clostridioides difficile infection
- Complicated urinary tract infections
- Intra-abdominal infections
Challenging, Rare, and Emerging Infectious Diseases
Comprehensive updates on:
- Rare and emerging infectious diseases, including highly pathogenic avian flu and Marburg virus
- Re-emergence of vaccine-preventable diseases, including poliomyelitis
- Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus
- Global infectious diseases of clinical importance
Clinical Decision-Making
Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:
- Selecting the best antimicrobial and duration of treatment
- Rapid detection and empiric treatment of life-threatening infectious diseases
- Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials
- Optimizing empiric antimicrobial therapy: what to start, and when to narrow or stop
Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:
- Antimicrobial stewardship to prevent resistance and reduce cost
- Infection control to reduce transmission in health care settings
- Early inpatient ID consultations to improve outcomes
- Strategies for management of infection in persons who inject drugs (PWID)
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Hospital.
Who Should Participate
Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:
- Infectious Diseases
- Hospital Medicine
- Internal Medicine
- Family Practice
- Pulmonary and Critical Care Medicine
- Emergency Medicine
...and others who care for patients with infectious diseases
Schedule
This program is among the highest-rated Harvard Medical School CME courses.
All agenda sessions are in Eastern Time.
Please note that program changes/substitutions may be made without notice.
Monday, May 4, 2026
Session 1: Monday Morning
Introduction and Road Map: Infectious Diseases of Adults
Dr. Nesli Basgoz
8:00-8:15 am
Antimicrobial Stewardship
Dr. Alyssa Letourneau
8:15-9:00 am
Update on Antifungal Diagnostics and Therapy
Dr. Michael Mansour
9:00-9:45 am
Break
9:45-10:00 am
Plenary: The Future of Global Public Health: Lessons from HIV
Dr. Linda-Gail Bekker
10:00-10:40 am
Live Q&A
Dr. Linda-Gail Bekker
10:40-11:00 am
Break
11:00-11:10 am
Eye and ENT Infections: What You Need to Know in 2026
Dr. Miriam Barshak
11:10 am-12:00 pm
Live Q&A
Drs. Miriam Barshak, Nesli Basgoz, Alyssa Letourneau, and Michael Mansour
12:00-12:30 pm
Break
12:30-1:30 pm
Session 2: Monday Afternoon
Multidisciplinary Panel Workshop #1: Resistant Gram-Positive Infections
Drs. Alyssa Letourneau, Roby Bhattacharyya, Ramy Elshaboury, and panelists
1:30-2:10 pm
Multidisciplinary Panel Workshop #2: Resistant Gram-Negative Infections
Drs. Alyssa Letourneau, Roby Bhattacharyya, Ramy Elshaboury, and panelists
2:10-2:50 pm
Live Q&A
Drs. Alyssa Letourneau, Roby Bhattacharyya, Ramy Elshaboury, and panelists
2:50-3:20 pm
Break
3:20-3:30 pm
C. difficile Update, the Gut Microbiome, and Pre- and Probiotics
Dr. Elizabeth Hohmann
3:30-4:15 pm
Skin and Soft Tissue Infections
Dr. Sandra Nelson
4:15-4:45 pm
Live Q&A
Drs. Sandra Nelson and Elizabeth Hohmann
4:45-5:05 pm
Tuesday, May 5, 2026
Session 3: Tuesday Morning
Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy
Dr. Camille Kotton
8:00-8:50 am
Infections in Hematologic Malignancies and Stem Cell Transplantation
Dr. Sarah Hammond
8:50-9:50 am
Break
Flummoxing Cases in Fungal Infections
Drs. Michael Mansour and Sarah Turbett
10:00-10:45 am
Live Q&A
Drs. Camille Kotton, Michael Mansour, Sarah Hammond, and Sarah Turbett
10:45-11:15 am
State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections
Dr. Kevin Ard
11:15 am-12:00 pm
Break
12:00-1:00 pm
Session 4: Tuesday Afternoon
Updates on COVID-19, Including Long COVID
Dr. Rajesh Gandhi
1:00-1:45 pm
Navigating New Vaccines: Updates and Recommendations
Dr. Camille Kotton
1:45-2:15 pm
Advanced Learning Module: HIV
Pre- and Post-Exposure Prophylaxis for HIV and STIs
Dr. Kevin Ard
2:15-2:55 pm
Break
2:55-3:05 pm
What's New in the Care of People with HIV in 2026
Dr. Rajesh Gandhi
3:05-3:50 pm
Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections
Dr. Nesli Basgoz
3:50-4:35 pm
Live Q&A
Drs. Rajesh Gandhi, Nesli Basgoz, Kevin Ard, and Camille Kotton
4:35-5:05 pm
Break
5:05-5:10 pm
Meet-the-Professors Case Discussion Session: HIV
(Repeat session offered on Wednesday morning--please choose only one)
5:10-6:05 pm
Self-Paced Study: HIV
6:05 pm
Prerecorded lectures
Perinatal HIV Infection
Dr. Andrea L. Ciaranello
Metabolic Complications of HIV
Dr. Virginia Triant
CROI Updates
Dr. Rajesh Gandhi
HIV Resistance
Dr. Suzanne McCluskey
Wednesday, May 6, 2026
Meet-the-Professors Case Discussion Session: HIV
(Repeat session offered on Tuesday evening--please choose only one)
7:00-7:55 am
Break
7:55-8:00 am
Session 5: Wednesday Morning
Introduction to TB, Latent TB Infection, and Drug-Susceptible TB
Dr. Jodian Pinkney
8:00-8:30 am
Drug-Resistant TB and TB in Special Populations
Dr. Rocio Hurtado
8:30-9:10 am
Live Q&A
Drs. Rocio Hurtado and Jodian Pinkney
9:10-9:25 am
Break
9:25-9:35 am
Bronchiectasis and NTM Infections: Anatomic and Clinical Approaches
Dr. Nesli Basgoz
9:35-10:20 am
The Latest on Major Respiratory Viral Infections
Dr. Michael Ison
10:20-10:50 am
Advances in Viral Hepatitis: HBV and HCV
Dr. Arthur Kim
10:50-11:40 am
Live Q&A
Drs. Nesli Basgoz, Rocio Hurtado, and Michael Ison
11:40 am-12:00 pm
Break
12:00-1:00 pm
Session 6: Wednesday Afternoon
Live: New England Journal of Medicine Clinicopathologic Conference (CPC)
1:00-2:00 pm
Tropical Medicine: 2026 Review and Update
Dr. Edward T. Ryan
2:00-2:35 pm
Cases in Global Infectious Diseases
Dr. Edward T. Ryan
2:35-3:15 pm
Live Q&A
Dr. Edward T. Ryan
3:15-3:30 pm
Break
3:30-3:40 pm
Advanced Learning Module: Mycobacterial Infections
Multidisciplinary Panel Workshop #3: Management of Complex Nontuberculous Mycobacterial Infection (NTM): Pulmonary
Dr. Rocio Hurtado and panelists
3:40-4:20 pm
Multidisciplinary Panel Workshop #4: Management of Complex Nontuberculous Mycobacterial Infection (NTM): Extrapulmonary
Dr. Rocio Hurtado and panelists
4:20-5:00 pm
Live Q&A
Dr. Rocio Hurtado and panelists
5:00-5:30 pm
Break
5:30-5:35 pm
Meet-the-Professors Case Discussion Session: Mycobacterial Infections
(Repeat session offered on Thursday morning--please choose only one)
5:35-6:30 pm
Thursday, May 7, 2026
Meet-the-Professors Case Discussion Session: Mycobacterial Infections
(Repeat session offered on Wednesday evening--please choose only one)
7:00-7:55 am
Break
7:55-8:00 am
Session 7: Thursday Morning
Encephalitis and Meningitis: Guidelines and Best Practices
Dr. Allan Tunkel
8:00-9:00 am
Tick Talk: Lyme Disease, Ehrlichia, Anaplasma, Babesia, and Rickettsia
Dr. Kimon Zachary
9:00-9:50 am
Live Q&A
Drs. Allan Tunkel and Kimon Zachary
9:50-10:05 am
Break
10:05-10:15 am
Bone and Joint infections: A Conceptual Framework
Dr. Sandra Nelson
10:15-11:05 am
Staphylococcus aureus: Déjà Vu All Over Again
Dr. Henry Chambers
11:05-11:55 am
Live Q&A
Drs. Sandra Nelson and Henry Chambers
11:55 am-12:10 pm
Break
12:10-1:10 pm
Session 8: Thursday Afternoon
Multidisciplinary Panel Workshop #5: Native Bone Infections
Dr. Sandra Nelson and panelists
1:10-1:50 pm
Multidisciplinary Panel Workshop #6: Orthopedic Device Infections: Prosthetic Joint Infections
Dr. Sandra Nelson and panelists
1:50-2:30 pm
Live Q&A
Dr. Sandra Nelson and panelists
2:30-3:00 pm
Break
3:00-3:10 pm
New and Emerging Viruses
Dr. Martin Hirsch
3:10-4:00 pm
KEYNOTE: Preparing for Future Pandemics
Dr. David Oshinsky
4:00-4:40 pm
Live Q&A
Drs. Martin Hirsch and David Oshinsky
4:40-5:10 pm
Friday, May 8, 2026
Session 9: Friday Morning
Intra-abdominal Infections: A Conceptual Framework
Dr. Nesli Basgoz
8:00-8:35 am
Urinary Tract Infections: A Conceptual Framework
Dr. Jacob Lazarus
8:35-9:10 am
Critical Care ID and Sepsis for the ID Clinician
Dr. Lisa Bebell
9:10-9:50 am
Live Q&A
Drs. Nesli Basgoz, Jacob Lazarus, and Lisa Bebell
9:50-10:20 am
Break
10:20-10:30 am
Multidisciplinary Workshop #7: Management of Complex Intra-abdominal Infections
Dr. Nesli Basgoz and panelists
10:30-11:10 am
Multidisciplinary Workshop #8: Management of Complex Urinary Tract Infections
Dr. Jacob Lazarus and panelists
11:10-11:50 am
Live Q&A
Drs. Nesli Basgoz, Jacob Lazarus, and panelists
11:50 am-12:20 pm
Break
12:20-1:20 pm
Endocarditis and Cardiac Device Infections
Dr. Molly Paras
1:20-2:15 pm
The Syndemic of SUD and Infection: Updated Approaches for 2026
Dr. Jennifer Johnson
2:15-3:00 pm
Live Q&A
Drs. Molly Paras and Jennifer Johnson
3:00-3:20 pm
Break
3:20-3:30 pm
Multidisciplinary Workshop #9: Management of Endocarditis
Dr. Molly Paras and panelists
3:30-4:10 pm
Multidisciplinary Workshop #10: Management of Cardiac Device Infections
Dr. Molly Paras and panelists
4:10-4:50 pm
Live Q&A
Dr. Molly Paras and panelists
4:50-5:20 pm
New for 2026: Meet-the-Professors Case Discussion Sessions
As part of Advanced Learning Modules in HIV and Mycobacterial Infections on Tuesday and Wednesday afternoons, you can now bring your cases to our expert faculty panels for discussion during our new Meet-the-Professors sessions. (Instructions for submitting your cases coming soon.)
For your convenience, we offer these Meet-the-Professors case discussion sessions on each topic twice, once in the early morning and once in the late afternoon/evening. If you would like to attend a Meet-the-Professors session on either HIV or Mycobacterial Infections, we ask that you choose only one session on each topic and let us know of your choice when you register for the course.
HIV Meet-the-Professors sessions
- Tuesday, May 5, 2026, 5:10–6:05 pm
Or - Wednesday, May 6, 2026, 7:00–7:55 am
Mycobacterial Infections Meet-the-Professors sessions
- Wednesday, May 6, 2026, 5:35–6:30 pm
Or - Thursday, May 7, 2026, 7:00–7:55 am
Optimized for Distance Learning
The 2026 program has been optimized for distance learning.
In addition to being live streamed, all sessions and Q & A discussions will be recorded and made available to participants for online viewing for 90 days after the end of the course. This on-demand archive will permit those in different time zones or who have scheduling conflicts to avoid missing out on any sessions that are important to them. In addition, participants can review sessions to reinforce key learning points.
All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
Learning Objectives
Upon completion of this course, participants will be able to:
- Utilize the latest strategies for the prevention, diagnosis, and management of important infectious disease syndromes in immunocompetent and immunocompromised patients
- Describe updated guidelines on the treatment of infectious diseases
- Summarize principles of judicious antimicrobial selection, dose, route, and duration to optimize patient outcomes while preventing resistance and lowering cost
- Describe evidence-based treatments as well as new treatment paradigms for resistant organisms and difficult-to-treat infections
- Recognize the role of novel, rapid diagnostics of infection and resistance in infectious disease practice
- Recognize the epidemiologic risk factors for emerging infectious diseases and provide optimal empiric and target therapies for infections
- Design and implement multidisciplinary care for patients in areas such as hematology oncology, solid organ transplantation, musculoskeletal infections, endocarditis, abdominal infections, and genitourinary infections
Faculty
Course Director
Nesli Basgoz
MD
- MGH Master Clinician Endowed Chair in Infectious Diseases
- Chief, Jackson Firm, Department of Medicine, Massachusetts General Hospital
- Associate Professor of Medicine, Harvard Medical School
Course Co-Directors
Ruanne V. Barnabas
MBChB, MSc, DPhil, FIDSA
- Chief, Division of Infectious Diseases
- MGH Francis and Dorothea Reed Endowed Chair in Infectious Diseases, Massachusetts General Hospital
- Professor of Medicine, Harvard Medical School
- Professor of Epidemiology, Harvard T.H. Chan School of Public Health
Rajesh T. Gandhi
MD
- Director, HIV Education, Division of Infectious Diseases, Massachusetts General Hospital
- Vice Chair, ACTG
- Co-Director, Harvard University Center for AIDS Research
- Professor of Medicine, Harvard Medical School
Sandra B. Nelson
MD
- Co-Clinical Director, Division of Infectious Diseases
- Director, Musculoskeletal Infectious Disease and Outpatient Parenteral Antibiotic Therapy Programs
- Division of Infectious Diseases, Massachusetts General Hospital
- Associate Professor of Medicine, Harvard Medical School
2026 faculty coming soon.
2026 faculty coming soon.
Course Fees
Fee Disclaimer
Registrations for Harvard Medical School CME programs are made via our secure online registration system. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate.
Please review the cancellation policy.
Early Registration Deadline:
| Role | Course Fee | Early Registration Course Fee |
|---|---|---|
| Physician (MD/DO) | $1,375.00 | $1,275.00 |
| Nurse (RN/APRN) | $1,375.00 | $1,275.00 |
| PA | $1,375.00 | $1,275.00 |
| Resident/Fellow | $995.00 | $895.00 |
| Allied Health Professional / Other | $1,375.00 | $1,275.00 |
All registrants of Infectious Diseases in Adults 2026 will receive an electronic syllabus.
All sessions will be recorded as they are live streamed and placed in the online course video library, so that registrants can review them at their convenience. The video library will be available for 90 days after the conclusion of the course.
Accreditation
The Harvard Medical School designates this live activity for a maximum of 45.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this knowledge-based activity for a maximum of 45.25 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN JA0000216-0000-26-001-L01-P.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 45.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 9.25 credits of Risk Management Study. This includes:
- 6.25 credits of Opioid Education and Pain Management Training.
Please check your individual state licensing board requirements before claiming these credits.
For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.